These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19300573)

  • 1. Eszopiclone: its use in the treatment of insomnia.
    Monti JM; Pandi-Perumal SR
    Neuropsychiatr Dis Treat; 2007 Aug; 3(4):441-53. PubMed ID: 19300573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placebo.
    Menza M; Dobkin RD; Marin H; Gara M; Bienfait K; Dicke A; Comella CL; Cantor C; Hyer L
    Mov Disord; 2010 Aug; 25(11):1708-14. PubMed ID: 20589875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Sleep Affects Epigastric Pain in Functional Dyspepsia by Reducing the Levels of Inflammatory Mediators.
    Du H; Lin R; Xiao S; Zhao Y; Wu M; Chen W; Cai W; Wei N; Gong G; Huang K; Zhang F; Chen H
    Dig Dis; 2023; 41(6):835-844. PubMed ID: 37607491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of eszopiclone combined with drug therapy in the treatment of insomnia after stroke: A network meta-analysis and systematic review.
    Li RY; Zhu DL; Chen KY
    PLoS One; 2024; 19(2):e0297064. PubMed ID: 38315683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of new hypnotic drugs on cognition: A systematic review and network meta-analysis.
    Zhou M; Liu R; Tang J; Tang S
    Sleep Med X; 2023 Dec; 6():100094. PubMed ID: 38149178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of insomnia in myasthenia gravis-A prospective study on non-benzodiazepine hypnotics in the treatment of myasthenia gravis patients with insomnia.
    Yan J; Yang M; Li MK; Huang Y; Tan Y; Shi J; Fan Q; Zhu Z; Guan Y; Cui L
    Front Neurol; 2023; 14():1266862. PubMed ID: 37808499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of lemborexant on insomnia in patients with psychiatric disorders: Detailed evaluation using the Athens Insomnia Scale.
    Murayama T; Ito Y; Narita K; Ishida T; Hinotsu S; Fujita M
    PCN Rep; 2024 Mar; 3(1):e165. PubMed ID: 38868465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ramelteon: a novel hypnotic indicated for the treatment of insomnia.
    Zammit GK
    Psychiatry (Edgmont); 2007 Sep; 4(9):36-42. PubMed ID: 20532119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Importance of Residual Effects When Choosing a Hypnotic: The Unique Profile of Zaleplon.
    Zammit GK; Kramer JA
    Prim Care Companion J Clin Psychiatry; 2001 Apr; 3(2):53-60. PubMed ID: 15014616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indiplon in the treatment of sleep disorders.
    Lankford A
    Neuropsychiatr Dis Treat; 2007 Dec; 3(6):765-73. PubMed ID: 19300612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Hypnotics in Patients with Insomnia and Heart Failure during Hospitalization: A Systematic Review.
    Jorge-Samitier P; Fernández-Rodrigo MT; Juárez-Vela R; Antón-Solanas I; Gea-Caballero V
    Nurs Rep; 2021 May; 11(2):373-381. PubMed ID: 34968214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of presumptive spot test for the identification of z-drugs used in drug-facilitated crimes.
    Chauhan V; Sharma M
    Forensic Sci Med Pathol; 2023 Oct; ():. PubMed ID: 37878164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose response of acute cocaine on sleep/waking behavior in mice.
    Bjorness TE; Greene RW
    Neurobiol Sleep Circadian Rhythms; 2018 Jun; 5():84-93. PubMed ID: 31236515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of benzodiazepine discontinuation among older adults: potential improvements on depressive symptoms.
    Allary A; Proulx-Tremblay V; Bélanger C; Hudon C; O'Connor K; Roberge P; Vasiliadis HM; Desrosiers C; Cruz-Santiago D; Grenier S
    Aging Ment Health; 2024 Jul; ():1-9. PubMed ID: 38952209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a short video on patients' motivation for dose reduction or cessation of hypnotics.
    Amagai M; Ozone M; Utsumi T; Hotchi A; Iwashita M; Yamadera W; Shigeta M
    Sleep Biol Rhythms; 2023 Jul; 21(3):299-308. PubMed ID: 38469082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural Products-Pyrazine Hybrids: A Review of Developments in Medicinal Chemistry.
    Chen GQ; Guo HY; Quan ZS; Shen QK; Li X; Luan T
    Molecules; 2023 Nov; 28(21):. PubMed ID: 37959859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapeutic management of insomnia and effects on sleep processes, neural plasticity, and brain systems modulating stress: A narrative review.
    Palagini L; Bianchini C
    Front Neurosci; 2022; 16():893015. PubMed ID: 35968380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypnotics and infections: disproportionality analysis of the U.S. Food & Drug Administration adverse event reporting system database.
    Meng L; Huang J; He Q; Zhao Y; Zhao W; Tan J; Sun S; Yang J
    J Clin Sleep Med; 2022 Sep; 18(9):2229-2235. PubMed ID: 35713182
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.